Increased survival in experimental rat heatstroke by continuous perfusion of interleukin-1 receptor antagonist

W. T. Chiu, T. Y. Kao, M. T. Lin

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

In order to assess the possible therapeutical value of interleukin-l receptor antagonist (IL-1 ra) in the treatment of heatstroke, we evaluated the effects of heatstroke on survival time (interval between onset of heatstroke and death), systemic and striatal hemodynamic changes, and extent of striatal neuronal damage in rats treated with saline or IL-1 ra. The survival time of the heatstroke rats which received normal saline (single injection or continuous perfusion) was about 17 min. The heatstroke-induced ischemic damage to striatal neurons was due to systemic arterial hypotension, intracranial hypertension, decreased cerebral perfusion, and striatal dopamine (DA) accumulation (275%). Rats treated with a single injection of IL-1 ra (200 μg/kg, i.v.) immediately after the onset of heatstroke survived much longer (91 min) than the controls. The prolongation of survival induced by IL-1 ra was brought about by attenuation of the arterial hypotension, intracranial hypertension, decreased cerebral perfusion, ischemic damage to striatal neurons, and striatal DA release value (204%). Furthermore, after continuous perfusion of IL-1 ra (200 μg/kg per h, i.v.) immediately after the onset of heatstroke, the striatal DA release value of the rats was further reduced to 140% while the survival time of the rats was prolonged to up to 10 h from the onset of heatstroke. Thus, it appears that continuous i.v. perfusion of IL-1 ra is a good choice for heatstroke therapy.

Original languageEnglish
Pages (from-to)159-163
Number of pages5
JournalNeuroscience Research
Volume24
Issue number2
DOIs
Publication statusPublished - Jan 1996

Fingerprint

Heat Stroke
Interleukin-1 Receptors
Corpus Striatum
Perfusion
Interleukin-1
Intracranial Hypertension
Hypotension
Dopamine
Interleukin Receptors
Injections
Dopaminergic Neurons
Hemodynamics
Neurons

Keywords

  • Blood pressure
  • Cerebral ischemia
  • Corpus striatum
  • Dopamine
  • Heatstroke
  • Interleukin-1 receptor antagonist

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Increased survival in experimental rat heatstroke by continuous perfusion of interleukin-1 receptor antagonist. / Chiu, W. T.; Kao, T. Y.; Lin, M. T.

In: Neuroscience Research, Vol. 24, No. 2, 01.1996, p. 159-163.

Research output: Contribution to journalArticle

@article{fb0abef5d7b04e65bee701e33a0563d6,
title = "Increased survival in experimental rat heatstroke by continuous perfusion of interleukin-1 receptor antagonist",
abstract = "In order to assess the possible therapeutical value of interleukin-l receptor antagonist (IL-1 ra) in the treatment of heatstroke, we evaluated the effects of heatstroke on survival time (interval between onset of heatstroke and death), systemic and striatal hemodynamic changes, and extent of striatal neuronal damage in rats treated with saline or IL-1 ra. The survival time of the heatstroke rats which received normal saline (single injection or continuous perfusion) was about 17 min. The heatstroke-induced ischemic damage to striatal neurons was due to systemic arterial hypotension, intracranial hypertension, decreased cerebral perfusion, and striatal dopamine (DA) accumulation (275{\%}). Rats treated with a single injection of IL-1 ra (200 μg/kg, i.v.) immediately after the onset of heatstroke survived much longer (91 min) than the controls. The prolongation of survival induced by IL-1 ra was brought about by attenuation of the arterial hypotension, intracranial hypertension, decreased cerebral perfusion, ischemic damage to striatal neurons, and striatal DA release value (204{\%}). Furthermore, after continuous perfusion of IL-1 ra (200 μg/kg per h, i.v.) immediately after the onset of heatstroke, the striatal DA release value of the rats was further reduced to 140{\%} while the survival time of the rats was prolonged to up to 10 h from the onset of heatstroke. Thus, it appears that continuous i.v. perfusion of IL-1 ra is a good choice for heatstroke therapy.",
keywords = "Blood pressure, Cerebral ischemia, Corpus striatum, Dopamine, Heatstroke, Interleukin-1 receptor antagonist",
author = "Chiu, {W. T.} and Kao, {T. Y.} and Lin, {M. T.}",
year = "1996",
month = "1",
doi = "10.1016/0168-0102(95)00987-6",
language = "English",
volume = "24",
pages = "159--163",
journal = "Neuroscience Research",
issn = "0168-0102",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Increased survival in experimental rat heatstroke by continuous perfusion of interleukin-1 receptor antagonist

AU - Chiu, W. T.

AU - Kao, T. Y.

AU - Lin, M. T.

PY - 1996/1

Y1 - 1996/1

N2 - In order to assess the possible therapeutical value of interleukin-l receptor antagonist (IL-1 ra) in the treatment of heatstroke, we evaluated the effects of heatstroke on survival time (interval between onset of heatstroke and death), systemic and striatal hemodynamic changes, and extent of striatal neuronal damage in rats treated with saline or IL-1 ra. The survival time of the heatstroke rats which received normal saline (single injection or continuous perfusion) was about 17 min. The heatstroke-induced ischemic damage to striatal neurons was due to systemic arterial hypotension, intracranial hypertension, decreased cerebral perfusion, and striatal dopamine (DA) accumulation (275%). Rats treated with a single injection of IL-1 ra (200 μg/kg, i.v.) immediately after the onset of heatstroke survived much longer (91 min) than the controls. The prolongation of survival induced by IL-1 ra was brought about by attenuation of the arterial hypotension, intracranial hypertension, decreased cerebral perfusion, ischemic damage to striatal neurons, and striatal DA release value (204%). Furthermore, after continuous perfusion of IL-1 ra (200 μg/kg per h, i.v.) immediately after the onset of heatstroke, the striatal DA release value of the rats was further reduced to 140% while the survival time of the rats was prolonged to up to 10 h from the onset of heatstroke. Thus, it appears that continuous i.v. perfusion of IL-1 ra is a good choice for heatstroke therapy.

AB - In order to assess the possible therapeutical value of interleukin-l receptor antagonist (IL-1 ra) in the treatment of heatstroke, we evaluated the effects of heatstroke on survival time (interval between onset of heatstroke and death), systemic and striatal hemodynamic changes, and extent of striatal neuronal damage in rats treated with saline or IL-1 ra. The survival time of the heatstroke rats which received normal saline (single injection or continuous perfusion) was about 17 min. The heatstroke-induced ischemic damage to striatal neurons was due to systemic arterial hypotension, intracranial hypertension, decreased cerebral perfusion, and striatal dopamine (DA) accumulation (275%). Rats treated with a single injection of IL-1 ra (200 μg/kg, i.v.) immediately after the onset of heatstroke survived much longer (91 min) than the controls. The prolongation of survival induced by IL-1 ra was brought about by attenuation of the arterial hypotension, intracranial hypertension, decreased cerebral perfusion, ischemic damage to striatal neurons, and striatal DA release value (204%). Furthermore, after continuous perfusion of IL-1 ra (200 μg/kg per h, i.v.) immediately after the onset of heatstroke, the striatal DA release value of the rats was further reduced to 140% while the survival time of the rats was prolonged to up to 10 h from the onset of heatstroke. Thus, it appears that continuous i.v. perfusion of IL-1 ra is a good choice for heatstroke therapy.

KW - Blood pressure

KW - Cerebral ischemia

KW - Corpus striatum

KW - Dopamine

KW - Heatstroke

KW - Interleukin-1 receptor antagonist

UR - http://www.scopus.com/inward/record.url?scp=0030030758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030030758&partnerID=8YFLogxK

U2 - 10.1016/0168-0102(95)00987-6

DO - 10.1016/0168-0102(95)00987-6

M3 - Article

C2 - 8929922

AN - SCOPUS:0030030758

VL - 24

SP - 159

EP - 163

JO - Neuroscience Research

JF - Neuroscience Research

SN - 0168-0102

IS - 2

ER -